CVS vs. DGX: CVS Health vs. Quest Diagnostics Stock Comparison
How do CVS Health (CVS) and Quest Diagnostics (DGX) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
CVS Health (CVS) and Quest Diagnostics (DGX) are both classified in the Health Care Services sub-industry within the broader Health Care Providers & Services industry, placing them in the closest GICS peer bucket.
| Profile Item | CVS | DGX |
|---|---|---|
| Name | CVS Health Corporation Common Stock | Quest Diagnostics Incorporated |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Services | Health Care Services |
| Market Capitalization | 107.28 billion USD | 28.21 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | February 21, 1973 | December 17, 1996 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | CVS | DGX |
|---|---|---|
| Total Return (1Y) | 11.41% | 45.88% |
| Total Return (3Y, Annualized) | 12.73% | 27.45% |
| Total Return (5Y, Annualized) | 1.70% | 14.84% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | CVS | DGX |
|---|---|---|
| Volatility (1Y, Annualized) | 34.14% | 24.06% |
| Beta (5Y) | 0.60 | 0.54 |
| Max Drawdown (5Y) | -56.79% | -28.62% |
| Avg. Volume (3M) | 8.60M | 1.00M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | CVS | DGX |
|---|---|---|
| Sharpe Ratio (1Y) | 0.21 | 1.73 |
| Sortino Ratio (1Y) | 0.28 | 3.16 |
Profitability
ROE (TTM)
Quest Diagnostics (DGX) at 15.32% sits in the top ROE quartile, while CVS Health (CVS) at 14.36% is closer to the peer norm — stronger capital efficiency for DGX.
CVS
Health Care Equipment & Services industry group
14.36%
- Max
- 47.61%
- CVS
- 14.36%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
DGX
Health Care Equipment & Services industry group
15.32%
- Max
- 47.61%
- DGX
- 15.32%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Quest Diagnostics (DGX) at 9.54% retains a top-quartile share of revenue as profit, ahead of CVS Health (CVS) at 2.64%, which keeps about the industry-typical share.
CVS
Health Care Equipment & Services industry group
2.64%
- Max
- 29.35%
- Q3
- 9.33%
- CVS
- 2.64%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
DGX
Health Care Equipment & Services industry group
9.54%
- Max
- 29.35%
- DGX
- 9.54%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Quest Diagnostics (DGX) at 15.63% operates in the top operating margin quartile, ahead of CVS Health (CVS) at 2.72%, which runs around its industry’s norm.
CVS
Health Care Equipment & Services industry group
2.72%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- CVS
- 2.72%
- Q1
- -0.28%
- Min
- -16.29%
DGX
Health Care Equipment & Services industry group
15.63%
- Max
- 35.43%
- DGX
- 15.63%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | CVS | DGX |
|---|---|---|
| ROE (TTM) | 14.36% | 15.32% |
| ROA (TTM) | 3.11% | 6.61% |
| Net Margin (TTM) | 2.64% | 9.54% |
| Operating Margin (TTM) | 2.72% | 15.63% |
| Gross Margin (TTM) | 13.72% | 33.18% |
Growth
Revenue Growth
Both CVS Health (CVS) at 7.85% and Quest Diagnostics (DGX) at 11.78% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Quest Diagnostics (DGX) at 13.78% is around its peer norm for EPS growth, while CVS Health (CVS) at -62.02% drops into the bottom quartile, signaling weaker earnings momentum.
Growth Metrics
| Metric | CVS | DGX |
|---|---|---|
| Revenue Growth (YoY) | 7.85% | 11.78% |
| Revenue Growth (3Y CAGR) | 7.63% | 3.74% |
| EPS Growth (YoY) | -62.02% | 13.78% |
| EPS Growth (3Y CAGR) | -24.73% | 3.16% |
Financial Strength
Current Ratio (MRQ)
Quest Diagnostics (DGX) at 1.70 keeps current ratio within its industry’s typical mid-range, while CVS Health (CVS) at 0.85 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for CVS.
CVS
Health Care Equipment & Services industry group
0.85
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- CVS
- 0.85
- Min
- 0.30
DGX
Health Care Equipment & Services industry group
1.70
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DGX
- 1.70
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Quest Diagnostics (DGX) at 0.80 carries an industry-typical debt-to-equity mix, while CVS Health (CVS) at 0.93 uses more debt funding than most peers.
CVS
Health Care Equipment & Services industry group
0.93
- Max
- 1.88
- CVS
- 0.93
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
DGX
Health Care Equipment & Services industry group
0.80
- Max
- 1.88
- Q3
- 0.91
- DGX
- 0.80
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | CVS | DGX |
|---|---|---|
| Current Ratio (MRQ) | 0.85 | 1.70 |
| Debt / Equity (MRQ) | 0.93 | 0.80 |
| Net Debt / EBITDA | 3.49 | 2.38 |
Dividends
Dividend Yield (TTM)
Both CVS Health (CVS) at 3.27% and Quest Diagnostics (DGX) at 1.33% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
CVS
Health Care Equipment & Services industry group
3.27%
- CVS
- 3.27%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DGX
Health Care Equipment & Services industry group
1.33%
- DGX
- 1.33%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both CVS Health (CVS) at 30.89% and Quest Diagnostics (DGX) at 25.10% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.
CVS
Health Care Equipment & Services industry group
30.89%
- CVS
- 30.89%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DGX
Health Care Equipment & Services industry group
25.10%
- DGX
- 25.10%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | CVS | DGX |
|---|---|---|
| Dividend Yield (TTM) | 3.27% | 1.33% |
| Dividend Payout Ratio (TTM) | 30.89% | 25.10% |
Valuation
P/E Ratio (TTM)
CVS Health (CVS) at 9.74 sits in the cheaper P/E ratio quartile, while Quest Diagnostics (DGX) at 25.46 is closer to its industry’s usual earnings multiple — a discount for CVS, though growth and earnings durability still matter.
CVS
Health Care Equipment & Services industry group
9.74
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- CVS
- 9.74
- Min
- 4.21
DGX
Health Care Equipment & Services industry group
25.46
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- DGX
- 25.46
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
CVS Health (CVS) at 0.26 sits in the cheaper P/S ratio quartile while Quest Diagnostics (DGX) at 2.38 prices around its industry’s middle — CVS costs less per dollar of sales, though read it alongside growth and margins.
CVS
Health Care Equipment & Services industry group
0.26
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- CVS
- 0.26
- Min
- 0.03
DGX
Health Care Equipment & Services industry group
2.38
- Max
- 8.80
- Q3
- 4.32
- DGX
- 2.38
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
CVS Health (CVS) at 1.33 sits in the lower P/B ratio quartile against book while Quest Diagnostics (DGX) at 3.68 is valued near its industry’s middle — CVS is cheaper on assets, though weigh it against ROE and asset quality.
CVS
Health Care Equipment & Services industry group
1.33
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- CVS
- 1.33
- Min
- -1.31
DGX
Health Care Equipment & Services industry group
3.68
- Max
- 11.68
- Q3
- 6.12
- DGX
- 3.68
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | CVS | DGX |
|---|---|---|
| P/E Ratio (TTM) | 9.74 | 25.46 |
| P/S Ratio (TTM) | 0.26 | 2.38 |
| P/B Ratio (MRQ) | 1.33 | 3.68 |
| Free Cash Flow Yield (TTM) | 11.02% | 3.09% |